GÖKCE, M. İ. Et Al. 2017. Can we predict chemotherapy response in patients with metastatic testicular cancer? Role of thrombocytosis as a novel marker. MINERVA UROLOGICA E NEFROLOGICA , vol.69, no.4 , 342-348.

GÖKCE, M. İ., Mermerkaya, M., SÜER, E., Afandiyev, F., & Baltaci, S., (2017). Can we predict chemotherapy response in patients with metastatic testicular cancer? Role of thrombocytosis as a novel marker. MINERVA UROLOGICA E NEFROLOGICA , vol.69, no.4, 342-348.

GÖKCE, MEHMET Et Al. "Can we predict chemotherapy response in patients with metastatic testicular cancer? Role of thrombocytosis as a novel marker," MINERVA UROLOGICA E NEFROLOGICA , vol.69, no.4, 342-348, 2017

GÖKCE, MEHMET İ. Et Al. "Can we predict chemotherapy response in patients with metastatic testicular cancer? Role of thrombocytosis as a novel marker." MINERVA UROLOGICA E NEFROLOGICA , vol.69, no.4, pp.342-348, 2017

GÖKCE, M. İ. Et Al. (2017) . "Can we predict chemotherapy response in patients with metastatic testicular cancer? Role of thrombocytosis as a novel marker." MINERVA UROLOGICA E NEFROLOGICA , vol.69, no.4, pp.342-348.

@article{article, author={MEHMET İLKER GÖKCE Et Al. }, title={Can we predict chemotherapy response in patients with metastatic testicular cancer? Role of thrombocytosis as a novel marker}, journal={MINERVA UROLOGICA E NEFROLOGICA}, year=2017, pages={342-348} }